Light Path™ Protein Production
Get to the clinic faster without increasing risk
At Lonza, we understand the challenges facing biotherapeutic protein and vaccine manufacturers related to the time and costs inherent in the drug discovery and development process. Light Path™ Protein Production Services are efficient, focused technology and production offerings for biotherapeutic proteins and vaccines. Light Path™ services allow you to leverage our industry-accepted mammalian and microbial expression platforms, that have met with consistent regulatory approval, to help you meet your Preclinical and Phase I manufacturing needs in an efficient, cost-effective manner.
The focused offerings of the Light Path™ Protein Production Services can help reduce the time to the clinic.
Light Path™ Services include:
- Gene to non-GMP production services
- Offerings for both mammalian and microbial expressed proteins and antibodies
- Technology access at a Lonza facility without research license fees
- Protein production for manufacturability, safety and efficacy testing
- Services for a wide range of biotherapeutic and vaccine candidates